A preclinical mouse model of invasive lobular breast cancer metastasis

Cancer Research

Volumn 73, Issue 1, 2013, Pages 353-363

  Doornebal, Chris W ^a,b   Klarenbeek, Sjoerd ^a   Braumuller, Tanya M ^a   Klijn, Christiaan N ^a,c   Ciampricotti, Metamia ^a   Hau, Cheei Sing ^a   Hollmann, Markus W ^b   Jonkers, Jos ^a   De Visser, Karin E ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOCETAXEL; DOXORUBICIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST METASTASIS; CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER TRANSPLANTATION; CARCINOGENESIS; CONTROLLED STUDY; DISEASE MODEL; DISTANT METASTASIS; FEMALE; GENE EXPRESSION PROFILING; LUNG METASTASIS; LYMPH NODE METASTASIS; MAMMARY GLAND; MASTECTOMY; MOUSE; NONHUMAN; PRIMARY TUMOR; PRIORITY JOURNAL; RECIPIENT; WILD TYPE;

ANIMALS; BREAST NEOPLASMS; CARCINOMA, LOBULAR; FEMALE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION;

EID: 84871992953     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-11-4208     Document Type: Article

References (28)

1. Gupta GP, Massagué J. Cancer metastasis: building a framework. Cell2006;127:679-95.
2. Talmadge JE, Fidler IJ. AACR Centennial Series: The biology of cancer metastasis: historical perspective. Cancer Res 2010;70:5649-69.
3. Valastyan S, Weinberg RA. Tumor metastasis: molecular insights and evolving paradigms. Cell 2011;147:275-92.
4. Joyce JA, Pollard JW. Microenvironmental regulation of metastasis. Nat Rev Cancer 2008;9:239-52.
5. Nguyen DX, Bos PD, Massagué J. Metastasis: from dissemination toorgan-specific colonization. Nat Rev Cancer 2009;9:274-84.
6. Müller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001;410:50-56.
7. Hiratsuka S, Nakamura K, Iwai S, Murakami M, Itoh T, Kijima H, et al. MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. Cancer Cell 2002;2:289-300.
8. Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, Costa C, et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 2005;438:820-7.
9. Kaplan RN, Rafii S, Lyden D. Preparing the "Soil": the premetastatic niche. Cancer Res 2006;66:11089-93.
10. Fantozzi A, Christofori G. Mouse models of breast cancer metastasis. Breast Cancer Res 2006;8:212.
11. Jonkers J, Derksen PWB. Modeling metastatic breast cancer in mice. J Mammary Gland Biol Neoplasia 2007;12:191-203.
12. Francia G, Cruz-Munoz W, Man S, Xu P, Kerbel RS. Mouse models of advanced spontaneous metastasis for experimental therapeutics. Nat Rev Cancer 2011;11:135-41.
13. Keller PJ, Lin AF, Arendt LM, Klebba I, Jones AD, Rudnick JA, et al. Mapping the cellular and molecular heterogeneity of normal and malignant breast tissues and cultured cell lines. Breast Cancer Res 2010;12:R87.
14. Derksen PWB, Liu X, Saridin F, van der Gulden H, Zevenhoven J, Evers B, et al. Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis. Cancer Cell 2006;10:437-449.
15. Rottenberg S, Nygren AOH, Pajic M, Leeuwen V, B FW, Van Der Heijden I, et al. Selective induction of chemotherapy resistance of mammary tumors in a conditional mouse model for hereditary breast cancer. Proc Natl Acad Sci U S A 2007;104:12117-22.
16. Klijn C, Holstege H, de Ridder J, Liu X, Reinders M, Jonkers J, et al. Identification of cancer genes using a statistical framework for multi-experiment analysis of nondiscretized array CGH data. Nucleic Acids Res 2008;36:e13.
17. de Ronde JJ, Klijn C, Velds A, Holstege H, Reinders MJ, Jonkers J, et al. KC-SMARTR: An R package for detection of statistically significant aberrations in multi-experiment aCGH data. BMC Res Notes 2010;3:298.
18. Arpino G, Bardou VJ, Clark GM, Elledge RM. Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome. Breast Cancer Res 2004;6:R146-56.
19. Leek RD, Lewis CE, Whitehouse R, Greenall M, Clarke J, Harris AL. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 1996;56:4625-9.
20. Tsutsui S, Yasuda K, Suzuki K, Tahara K, Higashi H, Era S. Macrophage infiltration and its prognostic implications in breast cancer: the relationship with VEGF expression and microvessel density. Oncol Rep 2005;14:425-31.
21. DeNardo DG, Barreto JB, Andreu P, Vasquez L, Tawfik D, Kolhatkar N, et al. CD4 +T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell 2009;16:91-102.
22. Cristofanilli M, Gonzalez-Angulo A, Sneige N, Kau S-W, Broglio K, Theriault RL, et al. Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes. J Clin Oncol 2005;23:41-48.
23. Khanna C, Hunter K. Modeling metastasis in vivo. Carcinogenesis 2005;26:513-23.
24. Marusyk A, Almendro V, Polyak K. Intra-tumour heterogeneity: a looking glass for cancer? Nat Rev Cancer 2012;12:323-34.
25. Gerlinger M, Rowan AJ, Horswell S, Larkin J, Endesfelder D, Gronroos E, et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 2012;366:883-92.
26. de Visser KE, Eichten A, Coussens LM. Paradoxical roles of the immune system during cancer development. Nat Rev Cancer 2006;6:24-37.
27. Talmadge JE, Singh RK, Fidler IJ, Raz A. Murine models to evaluate novel and conventional therapeutic strategies for cancer. Am J Pathol 2007;170:793-804.
28. Klein CA. Parallel progression of primary tumours and metastases. Nat Rev Cancer 2009;9:302-312.